Resection for an Extremely Rare Pleomorphic Carcinoma of the Mediastinal Lymph Nodes of Unknown Primary: A Case Report.

IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Yonago acta medica Pub Date : 2026-04-29 eCollection Date: 2026-05-01 DOI:10.33160/yam.2026.05.004
Ken Miwa, Takashi Ohno, Tatsuya Miyamoto, Hiroshige Nakamura
{"title":"Resection for an Extremely Rare Pleomorphic Carcinoma of the Mediastinal Lymph Nodes of Unknown Primary: A Case Report.","authors":"Ken Miwa, Takashi Ohno, Tatsuya Miyamoto, Hiroshige Nakamura","doi":"10.33160/yam.2026.05.004","DOIUrl":null,"url":null,"abstract":"<p><p>Pleomorphic carcinoma of the mediastinal lymph nodes with an unknown primary site is extremely rare. A 68-year-old man was referred to our department after an enlarged lymph node in the right upper mediastinum was noted on computed tomography. An irregular nodule was also detected in the right upper lobe, showing no change compared with findings from 2 years earlier. FDG-PET (18F-fluorodeoxyglucose positron emission tomography) revealed strong uptake only in the mediastinal lymph nodes. EBUS-TBNA (Endobronchial ultrasound-guided transbronchial needle aspiration) of the lymph nodes revealed findings consistent with pleomorphic carcinoma. No other abnormalities were identified, and surgery was performed. As rapid pathology of the pulmonary nodule revealed no malignant findings, right upper mediastinal lymph node dissection was performed. The final pathological diagnosis was pleomorphic carcinoma. No malignant lesions were identified in the lungs. The patient has remained under strict observation, with no recurrence detected 1 year after surgery. Mediastinal lymph node carcinoma of unknown primary involving pleomorphic carcinoma, which carries a poor prognosis, needs strict follow-up owing to the risk of developing a future primary lung tumor.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"69 2","pages":"213-217"},"PeriodicalIF":1.0000,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13198963/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yonago acta medica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.33160/yam.2026.05.004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Pleomorphic carcinoma of the mediastinal lymph nodes with an unknown primary site is extremely rare. A 68-year-old man was referred to our department after an enlarged lymph node in the right upper mediastinum was noted on computed tomography. An irregular nodule was also detected in the right upper lobe, showing no change compared with findings from 2 years earlier. FDG-PET (18F-fluorodeoxyglucose positron emission tomography) revealed strong uptake only in the mediastinal lymph nodes. EBUS-TBNA (Endobronchial ultrasound-guided transbronchial needle aspiration) of the lymph nodes revealed findings consistent with pleomorphic carcinoma. No other abnormalities were identified, and surgery was performed. As rapid pathology of the pulmonary nodule revealed no malignant findings, right upper mediastinal lymph node dissection was performed. The final pathological diagnosis was pleomorphic carcinoma. No malignant lesions were identified in the lungs. The patient has remained under strict observation, with no recurrence detected 1 year after surgery. Mediastinal lymph node carcinoma of unknown primary involving pleomorphic carcinoma, which carries a poor prognosis, needs strict follow-up owing to the risk of developing a future primary lung tumor.

原发不明的纵隔淋巴结多形性癌切除1例。
原发部位不明的纵隔淋巴结多形性癌极为罕见。一位68岁的男性在计算机断层扫描上发现右上纵隔淋巴结肿大后被转介到我科。右上叶也发现不规则结节,与2年前的发现相比没有变化。FDG-PET (18f -氟脱氧葡萄糖正电子发射断层扫描)显示仅在纵隔淋巴结有强烈的摄取。EBUS-TBNA(支气管超声引导下经支气管穿刺)淋巴结显示的结果与多形性癌一致。没有发现其他异常,并进行了手术。由于肺结节的快速病理检查未发现恶性肿瘤,我们进行了右上纵隔淋巴结清扫。最终病理诊断为多形性癌。肺部未见恶性病变。术后1年未发现复发,患者仍在严格观察中。未知原发纵隔淋巴结癌累及多形性癌,预后较差,有发展为原发性肺肿瘤的危险,需要严格随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Yonago acta medica
Yonago acta medica MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
1.60
自引率
0.00%
发文量
36
审稿时长
>12 weeks
期刊介绍: Yonago Acta Medica (YAM) is an electronic journal specializing in medical sciences, published by Tottori University Medical Press, 86 Nishi-cho, Yonago 683-8503, Japan. The subject areas cover the following: molecular/cell biology; biochemistry; basic medicine; clinical medicine; veterinary medicine; clinical nutrition and food sciences; medical engineering; nursing sciences; laboratory medicine; clinical psychology; medical education. Basically, contributors are limited to members of Tottori University and Tottori University Hospital. Researchers outside the above-mentioned university community may also submit papers on the recommendation of a professor, an associate professor, or a junior associate professor at this university community. Articles are classified into four categories: review articles, original articles, patient reports, and short communications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书